BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 33359888)

  • 1. Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.
    Modjtahedi BS; Wu J; Luong TQ; Gandhi NK; Fong DS; Chen W
    Ophthalmology; 2021 Aug; 128(8):1169-1179. PubMed ID: 33359888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II.
    Drinkwater JJ; Davis TME; Hellbusch V; Turner AW; Bruce DG; Davis WA
    Cardiovasc Diabetol; 2020 Mar; 19(1):43. PubMed ID: 32234054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins.
    Neugebauer R; Schroeder EB; Reynolds K; Schmittdiel JA; Loes L; Dyer W; Desai JR; Vazquez-Benitez G; Ho PM; Anderson JP; Pimentel N; O'Connor PJ
    JAMA Netw Open; 2020 Jan; 3(1):e1918554. PubMed ID: 31977057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
    Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
    Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
    Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
    Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.
    Klein R; Myers CE; Lee KE; Paterson AD; Cruickshanks KJ; Tsai MY; Gangnon RE; Klein BE
    JAMA Ophthalmol; 2015 Sep; 133(9):1054-61. PubMed ID: 26181138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals.
    Hayashi T; Kubota K; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Araki A; Noda M; Noto H; Sakuma I; Yoshizumi M; Ina K; Nomura H;
    Int J Cardiol; 2014 Dec; 177(3):860-6. PubMed ID: 25466567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary sodium and potassium excretion and risk of cardiovascular events.
    O'Donnell MJ; Yusuf S; Mente A; Gao P; Mann JF; Teo K; McQueen M; Sleight P; Sharma AM; Dans A; Probstfield J; Schmieder RE
    JAMA; 2011 Nov; 306(20):2229-38. PubMed ID: 22110105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study.
    Tan GS; Gan A; Sabanayagam C; Tham YC; Neelam K; Mitchell P; Wang JJ; Lamoureux EL; Cheng CY; Wong TY
    Ophthalmology; 2018 Apr; 125(4):529-536. PubMed ID: 29217148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SGLT2 inhibitors on cardiovascular and renal outcomes in type 2 diabetes: A meta-analysis with trial sequential analysis.
    Qiu M; Ding L; Zhou H
    Medicine (Baltimore); 2021 Mar; 100(10):e25121. PubMed ID: 33725910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy.
    Yashkin AP; Kravchenko J; Yashin AI; Sloan F
    Am J Hypertens; 2018 Jan; 31(2):220-227. PubMed ID: 28985276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
    Chen J; Budoff MJ; Reilly MP; Yang W; Rosas SE; Rahman M; Zhang X; Roy JA; Lustigova E; Nessel L; Ford V; Raj D; Porter AC; Soliman EZ; Wright JT; Wolf M; He J;
    JAMA Cardiol; 2017 Jun; 2(6):635-643. PubMed ID: 28329057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.
    Chan YH; Hai JJ; Lau KK; Li SW; Lau CP; Siu CW; Yiu KH; Tse HF
    BMC Cardiovasc Disord; 2017 Aug; 17(1):233. PubMed ID: 28836952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein BE; Myers CE; Howard KP; Klein R
    JAMA Ophthalmol; 2015 May; 133(5):503-10. PubMed ID: 25502808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk.
    Toth PP; Granowitz C; Hull M; Liassou D; Anderson A; Philip S
    J Am Heart Assoc; 2018 Aug; 7(15):e008740. PubMed ID: 30371242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa.
    Reddy S; Strunk A; Jemec GBE; Garg A
    JAMA Dermatol; 2020 Jan; 156(1):65-71. PubMed ID: 31721983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.